4th Quarter - Report

ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues involving: The Federal, Food, Drug and Cosmetic Act Patient Protection and Affordable Care Act The Food and Drug Administration Safety and Innovation Act (FDASIA)

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —
ARI MITTLEMAN —
VINCENT A. ROBERTI, SR. —
RICHARD CHARLES WHITE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

General reimbursement issues H.R. 4857/S.2980 Ensuring Equal Access to Treatments Act

LobbyistCovered position, as disclosed
STEVEN E IRIZARRY —
VINCENT A. ROBERTI, SR. —
RICHARD CHARLES WHITE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4857 (113th), S. 2980 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.